FDA Inspection 1132410 — Ascent Pharmaceuticals Inc

Ascent Pharmaceuticals Inc — FEI 3009518416

The FDA completed an inspection of Ascent Pharmaceuticals Inc on Oct 13, 2020 in Central Islip, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 13, 2020
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Central Islip, NY (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.